Physician

Pathology

Dr. Xiaoxian Li, MD

Xiaoxian Li, MD practices Pathology. Xiaoxian is a published doctor as well. He has 2 publications published. The latest was: Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling.

Publications

Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling.
Is PET-CT scan an effective tool to differentiate the ascites caused by abdominal malignancy and peritoneal tuberculosis?

Doctors Specialties

Surgical (Selective) Pathology
Pathology

Accepted Insurances

Education

University of Texas MD Anderson Cancer Center

Hospital

Emory University Hospital

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1871748319
Last Name Of The Provider	LI
First Name Of The Provider	XIAOXIAN
View All

Similar Doctors

	Dr. Daniel J. Brat, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jordan H. Berne, MD This Doctor is OpenDoctor Recommended.
	Dr. Christopher D. Hillyer, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Hyunsoo J. Chang, MD This Doctor is OpenDoctor Recommended.
	Dr. Andrew S. Neish, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Ralph N. Sams, MD
	Dr. Gabriel L. Sica, MD This Doctor is OpenDoctor Recommended.
	Dr. Nazmi V. Adsay, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. David R. Braxton, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Chukwuma O. Onyeagocha, MD This Doctor is OpenDoctor Recommended.